Based on the discovery by our Founder, Professor Shimon Sakaguchi, we are developing stable, functional-induced Tregs that are antigen-specific (S/F-iTregs). Our S/F-iTregs address the limitations of earlier attempts to create therapeutic Tregs and competitive advantages over CAR-Treg approaches.
| Employees | 9 (6 on RocketReach) |
| Founded | 2016 |
| Industry | Biotechnology Research |
Looking for a particular RegCell employee's phone or email?
Michael McCullar is the President, CEO and Representative Director of RegCell.
6 people are employed at RegCell.